The Principal Investigator proposes to examine the effect of bile acids on cholangiocyte biology, based on the premise that chronic liver diseases with prominent cholestasis may be the result of injury directed towards the epithelial cells lining the biliary tree (cholangiocytes). Increased cholangiocyte secretion and proliferation are hallmarks of bile duct injury, and appear to be adaptive responses to injury. This occurs in the presence of elevated local levels of bile acids. With the recent discovery of the apical bile acid transporter (ABAT) in cholangiocytes, the question arises as to how bile acids modify cholangiocyte biology. The hypothesis is proposed that bile acids are internalized and affect intracellular signaling. The studies will determine the transcriptional regulation, translocation, and activity of ABAT in cholangiocytes; the potential for ABAT promoting the """"""""chole-hepatic shunt"""""""" for uptake of bile acids from bile back into the circulation within the liver will also be examined. The effect of bile acids on intracellular PKC, Ca++ and ERK signaling pathways will be determined. The differential effects of endogenous bile acids vs. therapeutic bile acids also will be examined. These studies will provide a better understanding of how bile acids interact with cholangiocytes, and hence may improve understanding of the cholangiocyte adaptation to injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK054208-01A2
Application #
6129399
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Serrano, Jose
Project Start
2000-09-30
Project End
2005-06-30
Budget Start
2000-09-30
Budget End
2001-06-30
Support Year
1
Fiscal Year
2000
Total Cost
$202,272
Indirect Cost
Name
Scott and White Memorial Hospital
Department
Type
DUNS #
076697960
City
Temple
State
TX
Country
United States
Zip Code
76504
Yin, Deling; Yang, Xiaohua; Li, Hui et al. (2016) ?-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein. J Biol Chem 291:605-12
Jung, Dongju; York, J Philippe; Wang, Li et al. (2014) FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway. Pflugers Arch 466:1011-9
Xia, Xuefeng; Jung, Dongju; Webb, Paul et al. (2012) Liver X receptor ýý and peroxisome proliferator-activated receptor ýý regulate cholesterol transport in murine cholangiocytes. Hepatology 56:2288-96
Xia, Xuefeng; Demorrow, Sharon; Francis, Heather et al. (2007) Cholangiocyte injury and ductopenic syndromes. Semin Liver Dis 27:401-12
Xia, Xuefeng; Francis, Heather; Glaser, Shannon et al. (2006) Bile acid interactions with cholangiocytes. World J Gastroenterol 12:3553-63
Shifrin, Alexander L; Chirmule, Narendra; Gao, Guang-Ping et al. (2005) Innate immune responses to adenoviral vector-mediated acute pancreatitis. Pancreas 30:122-9
Marzioni, Marco; Glaser, Shannon; Francis, Heather et al. (2005) Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 128:121-37
Alpini, Gianfranco; Glaser, Shannon; Baiocchi, Leonardo et al. (2005) Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. Hepatology 41:1037-45
Alpini, Gianfranco; Kanno, Noriatsu; Phinizy, Jo Lynne et al. (2004) Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways. Am J Physiol Gastrointest Liver Physiol 286:G973-82
Francis, Heather; Glaser, Shannon; Ueno, Yoshiyuki et al. (2004) cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway. J Hepatol 41:528-37

Showing the most recent 10 out of 29 publications